申请人:Plexxikon Inc.
公开号:US20180099939A1
公开(公告)日:2018-04-12
Disclosed are compounds of Formula I(a):
or a pharmaceutically acceptable salt, a solvate, a tautomer, an isomer or a deuterated analog thereof, wherein R
4
, R
5
, R
6
, R
7
, G
1
, G
2
and Ring A are as described in any of the embodiments described in this disclosure; compositions thereof; and uses thereof.